A Recognized Leader in Cell and Gene Therapy (CGT)
The Cincinnati Children’s Applied Gene and Cell Therapy Center is a clinical-stage research, development, and manufacturing hub advancing the future of pediatric healthcare.
Originating from the Translational Core Laboratory established in 2003, the center has evolved into a nationally recognized leader in cell and gene therapy (CGT), offering comprehensive CDMO services and a proven track record in early-phase clinical trials.
With a $60 million investment and a cutting-edge facility, the center is expanding its capacity to deliver transformative therapies for children with cancer, blood diseases, and genetic disorders. This growth builds on more than 15 years of CGT expertise and reflects Cincinnati Children’s commitment to solving unmet medical needs through translational science.
